Emilia Antonucci Selected Research

Emilia Antonucci Research Topics

Disease

31	Hemorrhage 04/2024 - 04/2003
25	Atrial Fibrillation 03/2024 - 01/2003
16	Stroke (Strokes) 03/2024 - 10/2005
16	Venous Thromboembolism 02/2024 - 04/2004
8	Thrombosis (Thrombus) 04/2024 - 12/2008
8	Acute Coronary Syndrome 03/2021 - 01/2006
6	Pulmonary Embolism 12/2022 - 02/2013
6	Coronary Artery Disease (Coronary Atherosclerosis) 02/2011 - 01/2006
5	Venous Thrombosis (Deep-Vein Thrombosis) 12/2022 - 12/2003
5	Hypertension (High Blood Pressure) 01/2022 - 10/2005
4	Thromboembolism 01/2022 - 12/2003
3	Neoplasms (Cancer) 05/2023 - 11/2019
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2018 - 03/2014
2	Overweight 01/2023 - 12/2019
2	COVID-19 07/2022 - 01/2022
2	Renal Insufficiency (Renal Failure) 01/2017 - 01/2015
2	Embolism (Embolus) 05/2012 - 10/2005
2	Thrombophilia 10/2010 - 09/2005
2	Myocardial Infarction 10/2007 - 11/2006
1	Hyperlipidemias (Hyperlipidemia) 04/2024
1	Wounds and Injuries (Trauma) 05/2023
1	Short Bowel Syndrome 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Uterine Hemorrhage (Uterine Bleeding) 01/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021
1	Chronic Renal Insufficiency 11/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2019
1	Thrombocytopenia (Thrombopenia) 11/2019
1	Peripheral Arterial Disease 01/2017
1	Diabetes Mellitus 01/2017
1	Anemia 01/2017
1	Pulmonary Hypertension 07/2014
1	Heart Failure 10/2011
1	Transient Ischemic Attack 10/2011
1	Dyspnea (Shortness of Breath) 10/2010
1	Necrosis 10/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2007
1	Vascular Diseases (Vascular Disease) 03/2007
1	Dyslipidemias (Dyslipidemia) 06/2006
1	Left Ventricular Dysfunction 06/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2005
1	Embolic Stroke 01/2003

Drug/Important Bio-Agent (IBA)

26	AnticoagulantsIBA 03/2024 - 01/2003
15	Vitamin K FDA Link 05/2021 - 08/2011
12	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 10/2005
7	fibrin fragment D (D-dimer)IBA 12/2022 - 09/2005
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 03/2021 - 01/2017
3	CreatinineIBA 04/2024 - 01/2015
3	Clopidogrel (Plavix)FDA Link 03/2021 - 01/2006
3	Prothrombin (Factor II)IBA 01/2021 - 12/2003
3	Adenosine Diphosphate (ADP)IBA 02/2011 - 12/2008
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2007 - 01/2006
2	TicagrelorIBA 03/2021 - 01/2019
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 03/2016
2	factor V LeidenIBA 01/2021 - 12/2003
2	FibrinIBA 07/2014 - 03/2013
1	Antiphospholipid AntibodiesIBA 04/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023
1	apixabanIBA 12/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	AcenocoumarolIBA 03/2021
1	GlycosaminoglycansIBA 03/2021
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 03/2021
1	Factor V (Coagulation Factor V)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2019
1	DiureticsIBA 11/2019
1	Prasugrel Hydrochloride FDA Link 01/2019
1	MetalsIBA 01/2017
1	Fibrinolysin FDA Link 07/2014
1	starlicideIBA 10/2010
1	prothrombin fragment 1IBA 10/2010
1	CoumarinsIBA 09/2009
1	CollagenIBA 12/2008
1	AntioxidantsIBA 03/2007
1	Fibrinogen (Factor I)FDA Link 06/2006
1	C-Reactive ProteinIBA 06/2006
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2006
1	AntigensIBA 01/2006
1	HomocysteineIBA 10/2005

Therapy/Procedure

28	Therapeutics 04/2024 - 01/2003
4	Percutaneous Coronary Intervention 03/2021 - 11/2006
3	Secondary Prevention 01/2021 - 02/2009
2	Length of Stay 07/2022 - 01/2022
1	Duration of Therapy 02/2024
1	Home Parenteral Nutrition 01/2022
1	Hormonal Contraception 01/2021
1	Prostheses and Implants (Prosthesis) 09/2018
1	Drug-Eluting Stents 01/2017
1	Electric Countershock (Cardioversion) 05/2012
1	Thrombolytic Therapy 10/2011
1	Electrodes (Electrode) 06/2009
1	Stents 12/2008